{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:08:17Z","timestamp":1791900497720,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T00:00:00Z","timestamp":1166054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T00:00:00Z","timestamp":1166054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1038\/sj.leu.2404500","type":"journal-article","created":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T17:20:20Z","timestamp":1166116820000},"page":"270-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":178,"title":["Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients"],"prefix":"10.1038","volume":"21","author":[{"given":"N","family":"Gangat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A P","family":"Wolanskyj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R F","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Schwager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,14]]},"reference":[{"key":"BF2404500_CR1","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","volume":"67","author":"C Rozman","year":"1991","unstructured":"Rozman C, Giralt M, Feliu E, Rubio D, Cortes MT . Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991; 67: 2658\u20132663.","journal-title":"Cancer"},{"key":"BF2404500_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I","volume":"61","author":"RA Mesa","year":"1999","unstructured":"Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A . Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County study, 1976\u20131995. Am J Hematol 1999; 61: 10\u201315.","journal-title":"Am J Hematol"},{"key":"BF2404500_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000204873","volume":"85","author":"F Cervantes","year":"1991","unstructured":"Cervantes F, Tassies D, Salgado C, Rovira M, Pereira A, Rozman C . Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. Acta Haematol 1991; 85: 124\u2013127.","journal-title":"Acta Haematol"},{"key":"BF2404500_CR4","first-page":"215","volume":"89","author":"T Barbui","year":"2004","unstructured":"Barbui T, Barosi G, Grossi A, Gugliotta L, Liberato LN, Marchetti M et al. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 2004; 89: 215\u2013232.","journal-title":"Haematologica"},{"key":"BF2404500_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2141.2005.05543.x","volume":"130","author":"CN Harrison","year":"2005","unstructured":"Harrison CN . Essential thrombocythaemia: challenges and evidence-based management. Br J Haematol 2005; 130: 153\u2013165.","journal-title":"Br J Haematol"},{"key":"BF2404500_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","volume":"128","author":"MA Elliott","year":"2005","unstructured":"Elliott MA, Tefferi A . Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2005; 128: 275\u2013290.","journal-title":"Br J Haematol"},{"key":"BF2404500_CR7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","volume":"332","author":"S Cortelazzo","year":"1995","unstructured":"Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995; 332: 1132\u20131136.","journal-title":"N Engl J Med"},{"key":"BF2404500_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa043800","volume":"353","author":"CN Harrison","year":"2005","unstructured":"Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D et al. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 2005; 353: 33\u201345.","journal-title":"N Engl J Med"},{"key":"BF2404500_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","volume":"117","author":"F Passamonti","year":"2004","unstructured":"Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med 2004; 117: 755\u2013761.","journal-title":"Am J Med"},{"key":"BF2404500_CR10","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/sj.leu.2402638","volume":"16","author":"P Bernasconi","year":"2002","unstructured":"Bernasconi P, Boni M, Cavigliano PM, Calatroni S, Brusamolino E, Passamonti F et al. Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea. Leukemia 2002; 16: 2078\u20132083.","journal-title":"Leukemia"},{"key":"BF2404500_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1532\/IJH97.06009","volume":"83","author":"K Dan","year":"2006","unstructured":"Dan K, Yamada T, Kimura Y, Usui N, Okamoto S, Sugihara T et al. Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the Japanese elderly leukemia and lymphoma study group. Int J Hematol 2006; 83: 443\u2013449.","journal-title":"Int J Hematol"},{"key":"BF2404500_CR12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V91.2.616","volume":"91","author":"Y Sterkers","year":"1998","unstructured":"Sterkers Y, Preudhomme C, Lai JL, Demory JL, Caulier MT, Wattel E et al. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood 1998; 91: 616\u2013622.","journal-title":"Blood"},{"key":"BF2404500_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4065\/81.2.159","volume":"81","author":"AP Wolanskyj","year":"2006","unstructured":"Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A . Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 2006; 81: 159\u2013166.","journal-title":"Mayo Clin Proc"},{"key":"BF2404500_CR14","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1001\/archinte.165.22.2651","volume":"165","author":"CS Chim","year":"2005","unstructured":"Chim CS, Kwong YL, Lie AK, Ma SK, Chan CC, Wong LG et al. Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia. Arch Intern Med 2005; 165: 2651\u20132658.","journal-title":"Arch Intern Med"},{"key":"BF2404500_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s002770050555","volume":"78","author":"M Bazzan","year":"1999","unstructured":"Bazzan M, Tamponi G, Schinco P, Vaccarino A, Foli C, Gallone G et al. Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia. Ann Hematol 1999; 78: 539\u2013543.","journal-title":"Ann Hematol"},{"key":"BF2404500_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1055\/s-2006-942757","volume":"32","author":"HM Kvasnicka","year":"2006","unstructured":"Kvasnicka HM, Thiele J . The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera. Semin Thromb Hemost 2006; 32: 362\u2013371.","journal-title":"Semin Thromb Hemost"},{"key":"BF2404500_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","volume":"66","author":"P Fenaux","year":"1990","unstructured":"Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F . Clinical course of essential thrombocythemia in 147 cases. Cancer 1990; 66: 549\u2013556.","journal-title":"Cancer"},{"key":"BF2404500_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1365-2141.2000.02188.x","volume":"110","author":"G Finazzi","year":"2000","unstructured":"Finazzi G, Ruggeri M, Rodeghiero F, Barbui T . Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial. Br J Haematol 2000; 110: 577\u2013583.","journal-title":"Br J Haematol"},{"key":"BF2404500_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1055\/s-2006-942762","volume":"32","author":"JJ Kiladjian","year":"2006","unstructured":"Kiladjian JJ, Rain JD, Bernard JF, Briere J, Chomienne C, Fenaux P . Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia. Semin Thromb Hemost 2006; 32: 417\u2013421.","journal-title":"Semin Thromb Hemost"},{"key":"BF2404500_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/10428190500331329","volume":"47","author":"J Thiele","year":"2006","unstructured":"Thiele J, Kvasnicka HM . A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders. Leuk Lymphoma 2006; 47: 381\u2013396.","journal-title":"Leuk Lymphoma"},{"key":"BF2404500_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0895-4356(95)00031-3","volume":"49","author":"E Kokmen","year":"1996","unstructured":"Kokmen E, Ozsarfati Y, Beard CM, O'Brien PC, Rocca WA . Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. J Clin Epidemiol 1996; 49: 79\u201383.","journal-title":"J Clin Epidemiol"},{"key":"BF2404500_CR22","first-page":"17","volume-title":"World Health Organization Classification of Tumors: Tumours of the Haematopoietic and Lymphoid Tissues","author":"JW Vardiman","year":"2001","unstructured":"Vardiman JW, Brunning RD, Harris NL . WHO histological classification of chronic myeloproliferative diseases. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumors: Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer (IARC) Press, 2001, pp. 17\u201344."},{"key":"BF2404500_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1053\/j.seminoncol.2005.04.010","volume":"32","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM . Hematopathologic findings in chronic idiopathic myelofibrosis. Semin Oncol 2005; 32: 380\u2013394.","journal-title":"Semin Oncol"},{"key":"BF2404500_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451\u2013458.","journal-title":"Br J Haematol"},{"key":"BF2404500_CR25","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","volume":"106","author":"DP Steensma","year":"2005","unstructured":"Steensma DP, Dewald GW, Lasho TL, Powell HL, McClure RF, Levine RL et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u2018atypical\u2019 myeloproliferative disorders and myelodysplastic syndromes. Blood 2005; 106: 1207\u20131209.","journal-title":"Blood"},{"key":"BF2404500_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.leukres.2004.07.014","volume":"29","author":"AI Cabello","year":"2005","unstructured":"Cabello AI, Collado R, Ruiz MA, Martinez J, Navarro I, Ferrer R et al. A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals. Leuk Res 2005; 29: 365\u2013370.","journal-title":"Leuk Res"},{"key":"BF2404500_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/sj.leu.2401298","volume":"13","author":"A Merlat","year":"1999","unstructured":"Merlat A, Lai JL, Sterkers Y, Demory JL, Bauters F, Preudhomme C et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases. Leukemia 1999; 13: 250\u2013257.","journal-title":"Leukemia"},{"key":"BF2404500_CR28","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/sj.leu.2402713","volume":"16","author":"N Mauritzson","year":"2002","unstructured":"Mauritzson N, Albin M, Rylander L, Billstrom R, Ahlgren T, Mikoczy Z et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976\u20131993 and on 5098 unselected cases reported in the literature 1974\u20132001. Leukemia 2002; 16: 2366\u20132378.","journal-title":"Leukemia"},{"key":"BF2404500_CR29","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/sj.leu.2402176","volume":"15","author":"JA Hernandez","year":"2001","unstructured":"Hernandez JA, Florensa L, Sole F, Bosch MA, Espinet B . Acute myeloid leukemia with 17p abnormality in untreated essential thrombocythemia. Leukemia 2001; 15: 1308.","journal-title":"Leukemia"},{"key":"BF2404500_CR30","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1182\/blood.V92.4.1459","volume":"92","author":"A Tefferi","year":"1998","unstructured":"Tefferi A . Is hydroxyurea leukemogenic in essential thrombocythemia. Blood 1998; 92: 1459\u20131460.","journal-title":"Blood"},{"key":"BF2404500_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1365-2141.1998.00529.x","volume":"100","author":"E Lengfelder","year":"1998","unstructured":"Lengfelder E, Hochhaus A, Kronawitter U, Hoche D, Queisser W, Jahn-Eder M et al. Should a platelet limit of 600 \u00d7 10(9)\/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br J Haematol 1998; 100: 15\u201323.","journal-title":"Br J Haematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404500","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:42:17Z","timestamp":1648780937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,14]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2,1]]}},"alternative-id":["BF2404500"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404500","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,14]]},"assertion":[{"value":"7 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}